Zobrazeno 1 - 10
of 702
pro vyhledávání: '"H Vierhapper"'
Autor:
S. Kleinle, H. Vierhapper, M. Födinger, G. Fischer, R. Lang, Sabina Baumgartner-Parzer, F. Waldhauser
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 94:3954-3958
Rare haplotypes with Q318X mutations and duplicated CYP21A2 genes have been reported to occur in different populations to a varying extent. Discrimination between a normal (Q318X mutation on one of the duplicated CYP21A2 genes) and a congenital adren
Autor:
H. Vierhapper, P. Damjancic
Publikováno v:
Experimental and Clinical Endocrinology & Diabetes. 95:315-321
To study the potential impact of glucocorticoids on the effects of human atrial natriuretic peptide (hANP) in man, the diuretic and natriuretic response to intravenous bolus doses of hANP (50 and 100 micrograms) was studied in seven male patients wit
Autor:
S. Begic-Karup, Werner Waldhäusl, H. Vierhapper, Brunhilde Wagner, Barbara Schneider, W. Raber
Publikováno v:
Experimental and Clinical Endocrinology & Diabetes. 107:457-461
Primary Hyperparathyroidism (PHP) often goes unrecognised. Evidence of the influence of thyroid diseases on parathyroid activity exists. In order to determine the prevalence of primary hyperparathyroidism (PHP) in patients with thyroid diseases, a se
Autor:
H. Vierhapper, W. Waldhäusl
Publikováno v:
Andrologia. 11:445-448
Zusammenfassung Ein neues LH-RH-Analogon mit prolongierter und verstarkter Wirkung, D-Ser-(TBU)6 - EA10-LH-RH, fuhrt bei gesunden Mannern zu einem qualitativ anderen Sekretionsmuster von LH und FSH als bei gesunden Frauen. Patientinnen mit angeborene
Publikováno v:
DMW - Deutsche Medizinische Wochenschrift. 108:570-577
Long-term ambulatory continuous subcutaneous insulin infusion was undertaken under serial blood-glucose control in nine insulin-dependent diabetics. Before this treatment was started, haemoglobin A1 was increased (more than 13%), diabetic lipoid necr
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 92:1164-1167
Context: Although CYP21A2 de novo mutations are assumed to account for 1 to 2% of congenital adrenal hyperplasia (CAH) alleles and CYP21 genotyping has been done worldwide, there are only a few well-documented cases of CYP21A2 de novo mutations. The
Publikováno v:
Experimental and Clinical Endocrinology & Diabetes. 114:389-392
Poor compliance or drug malabsorption are the most common reasons why an adequate TSH suppression is not achieved with oral levothyroxin in patients with hypothyroidism or thyroid carcinoma. When these conditions are excluded rare causes have to be c
Publikováno v:
Thyroid. 15:1267-1272
To identify patients with medullary thyroid carcinoma (MTC) at a potentially curable stage of the disease, serum concentrations of calcitonin (hCT) were determined in 14,000 patients (including 10,158 patients with thyroid nodules) referred to a thyr
Autor:
Werner Waldhäusl, Klaus Kaserer, Bruno Niederle, R. Lang, Georg Heinze, Sabina Baumgartner-Parzer, Ludwig Wagner, H. Vierhapper
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 90:6232-6236
Context: Single-nucleotide polymorphisms (SNPs) of the RET protooncogene (RET) could modify disease susceptibility and clinical phenotype in patients with sporadic or familial medullary thyroid carcinoma (FMTC). Objective/Design of the Study: Because
Autor:
H. Vierhapper, L. Wagner, Christian Bieglmayer, S. Hanslik, S. Rondot, E Schulze, Klaus Kaserer, Sabina Baumgartner-Parzer, B. Niederle
Publikováno v:
Thyroid. 15:1303-1308
Primary hyperparathyroidism (PHP; serum calcium 2.75 mmol/L, PTH 226 pg/ml) had been the first clinical manifestation of MEN-2A in a female patient (aged 55 years) with a mutation (Y791F, TAT--TTT) in exon 13 of the RET proto-oncogene. The patient ha